{"nct_id":"NCT03939026","title":"Safety and Efficacy of ALLO-501 Anti-CD19 Allogeneic CAR T Cells in Adults With Relapsed/Refractory Large B Cell or Follicular Lymphoma","status":"ACTIVE_NOT_RECRUITING","status_verified_date":"2023-11","start_date":"2019-05-01","start_date_type":"ACTUAL","primary_completion_date":"2021-10-23","primary_completion_date_type":"ACTUAL","completion_date":"2026-08","completion_date_type":"ESTIMATED","phases":["PHASE1"],"tickers":["ALLO"]}